Bahrain approved today, Thursday, the emergency use of the “Johnson & Johnson” vaccine against the Corona virus, which is given in a single dose.
The National Health Regulatory Authority has approved the emergency use of the vaccine produced by “Johnson & Johnson” against the Corona virus (Covid-19), so that the company’s vaccine called “Jansen” is the fifth vaccine authorized in the Kingdom of Bahrain for emergency use of groups at high risk of developing complications. Coronavirus is from the elderly, people with chronic diseases, and other groups determined by the Ministry of Health with the aim of providing anti-virus vaccines.
Dr. Maryam Athbi Al-Jalahma, Chief Executive Officer of the authority stated that “an in-depth study has been carried out for all the documents submitted by the company, which included the results of the immunization study. Provided by the company about the results of studies on the vaccine that were conducted in several countries and the results of immunity.
Source:al wakalat